166: REST – a Dutch/UK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancer. (January 2015) - Faivre-Finn, C.; Hatton, M.Q.; Snee, M.; Jain, P.; Wilson, P.; McMenemin, R.; Peedell, C.; Bates, A.; Garcia, A.; Ironside, J.; Falk, S.; Van Tinteren, H.; et al.